This wiki has undergone a migration to Confluence found Here
Difference between revisions of "2016-06-22 SGB Conference Call"
Jump to navigation
Jump to search
Line 60: | Line 60: | ||
|colspan="4" style="background:#f0f0f0;"| | |colspan="4" style="background:#f0f0f0;"| | ||
|- | |- | ||
− | |colspan="4" style="font-style:italic; color:green;" |'' | + | |colspan="4" style="font-style:italic; color:green;" |''Chair plus 4'' |
|} | |} |
Revision as of 14:03, 22 June 2016
back to Standards Governance Board main page
HL7 SGB Minutes |
Date: 2016-06-22 Time: 10:00 AM Eastern | ||
Facilitator | Paul/Calvin | Note taker(s) | Anne |
Attendee | Name
| ||
Calvin Beebe | |||
Lorraine Constable | |||
Russ Hamm | |||
Tony Julian | |||
Paul Knapp | |||
Austin Kreisler | |||
Wayne Kubick | |||
Mary Kay McDaniel | |||
Ken McCaslin | |||
Rik Smithies | |||
Chair plus 4 |
Agenda
- Agenda review
- Minutes review of 2016-06-15_SGB_Conference_Call
- Discussion Topics
- Risk assessment
- Defining the role of product director - joint with ARB
- Need to invite Grahame to discuss
- CDA Product Family Formation
- Further discussion on SGB Guidance on IG Conformance Statements (from 2016-02-22 TSC Call)
- Role of Steering Divisions
- FHIR Governance Board
- Balloting standards which are cross-product family
Minutes
Meeting Outcomes
Actions
|
Next Meeting/Preliminary Agenda Items |
© 2016 Health Level Seven® International. All rights reserved